Stocks and Investing
Stocks and Investing
Tue, June 20, 2017
Mon, June 19, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, June 16, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, June 15, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Irina Rivkind Koffler Upgraded (TEVA) to Hold and Increased Target to $30 on, Jun 15th, 2017
Published on 2024-10-25 21:21:49 - WOPRAI, Irina Rivkind Koffler
Irina Rivkind Koffler of Mizuho, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Increased Target from $25 to $30 on, Jun 15th, 2017.
Irina has made no other calls on TEVA in the last 4 months.
There is 1 other peer that has a rating on TEVA. Out of the 1 peers that are also analyzing TEVA, all agrees with Irina's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- John Eade of "Argus Research" Downgraded at Hold on, Tuesday, February 28th, 2017
Contributing Sources